P1.237. Clinical Significance of Cervical Lymph Node Dissection for Esophageal Squamous Cell Carcinoma

Clicks: 3
ID: 325744
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #182 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer – long term outcomes Background The clinical significance of cervical lymph node (LN) dissection in esophageal squamous cell carcinoma (ESCC) remains uncertain. This study aimed to clarify its clinical relevance by evaluating the prognostic impact of cervical LN metastasis in patients undergoing three-field lymph node dissection (3FLND). Methods Patients with pathologically confirmed ESCC who underwent curative esophagectomy with 3FLND between 2010 and 2025 at a tertiary center in Taiwan were retrospectively reviewed. Patients were classified into cervical LN (+), non-cervical LN (+), and node-negative groups. Clinical features, tumor site, substances use, surgical complications, and survival outcomes were compared. Prognostic factors for overall survival (OS) and progression-free survival (PFS) were analyzed. Results A total of 521 patients undergoing 3FLND were included: 52 (10.0%) had cervical LN metastasis, 130 (25.0%) had non-cervical LN metastasis, and 339 (65.1%) were node-negative. Cervical LN positivity was associated with tumor site (p=0.020). No significant differences in morbidity rates (p=0.622) were observed across the three groups, including lymphatic leakage or pulmonary complications. Median OS was 13.5 months in the cervical LN (+) group (5-year OS: 9.1%) and 12.2 months in the non-cervical LN (+) group (5-year OS: 18.3%). Median PFS was 8.2 vs. 9.1 months (5-year PFS: 9.0% vs. 18.9%) in the respective groups. In multivariate analysis, pN stage independently predicted worse OS and PFS, while no significant survival difference was observed between cervical LN (+) and non-cervical LN (+) patients. Conclusion Cervical LN metastasis was not infrequent in ESCC patients and was significantly associated with tumor location. Following cervical lymph node dissection, survival outcomes were comparable between patients with cervical and non-cervical LN metastasis. Given its appreciable incidence, identifiable risk factor, acceptable morbidity, and equivalent post-dissection survival, we suggest that the role of 3FLND in ESCC be carefully reinvestigated in contemporary surgical practice.
Reference Key
openalex_W7203944149 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yu-An Zheng, Jang‐Ming Lee
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.385
URL
https://doi.org/10.1093/dote/doag077.385
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.